Madrigal Pharmaceuticals's total assets for Q3 2024 were $1.07B, a decrease of -2.41% from the previous quarter. MDGL total liabilities were $296.11M for the fiscal quarter, a 22.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.